Veritable’s Trinity Biotech TRIB Stock Holding History

Veritable’s Portfolio TRIB Stock Details TRIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-3,000	Closed	-$253K	–	977
2013 Q2	$253K	Buy	+3,000	New	+$249K	0.01%	785

Other funds holding TRIB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

AAM

ACK Asset Management Greenwich, Connecticut $801M AUM 60.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CIP

Chartwell Investment Partners Berywn, Pennsylvania $2.91B AUM 40.48% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

LSC

Lyon Street Capital Sausalito, California $67M AUM

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Veritable's TRIB Position: Q3 2013 in Review

Veritable sold out of Trinity Biotech (TRIB) in Q3 2013, closing a stake of 3,000 shares — an estimated $253K sold.

Veritable first reported a position in TRIB in Q2 2013 and held it in 1 quarter. The position peaked at $253K in Q2 2013. 70 funds tracked by Wall St. Rank hold TRIB as of Q3 2013.

Veritable reported no remaining Trinity Biotech position as of Q3 2013 after selling out during the quarter.
Veritable sold 3,000 Trinity Biotech shares in Q3 2013, an estimated $253K.
Veritable first reported a position in Trinity Biotech in Q2 2013 and held it in 1 quarter.
Veritable's Trinity Biotech position peaked at $253K in Q2 2013.
70 funds tracked by Wall St. Rank held Trinity Biotech as of Q3 2013.

Based on Veritable's 13F filing for Q3 2013, filed 13 Nov 2013.